This week: rescue dogs on the catwalk, dog mats go upscale, and the Flintstones got it wrong about Dino
This week: Dogs get banned, a rescue backfires, and your pet wants to know if there’s anything good on Netflix.
Which caregivers should be allowed to put their hands on a client’s pet? And under what circumstances? For that matter, what constitutes a qualified caregiver? A bill is coming to a vote before the California State Assembly’s Committee on Business and Professions next Tuesday that could change the answers to those questions, at least in California, and pose some thorny new ones with serious implications for the veterinary industry nationwide.
This week: a Staffordshire terrier peers reviews papers, Colorado pays the tab for large animal vet students, and who gets the dog in a divorce?
A new study by researchers at the University of Pennsylvania’s Perelman School of Medicine and the School of Veterinary Medicine reviewed all opioids dispensed at the veterinary school for from January 2007 through December 2017. The findings show that prescriptions rose 41% annually, while the number of patient visits rose only 13%.The researchers found the ratio worrisome.
The opioid shortage is both a manufacturing issue and a manufactured one. The manufacturing part can be traced back to production issues at a Pfizer Inc. plant in Kansas and residual damage from last year’s Hurricane Maria in Puerto Rico, a major pharmaceutical manufacturing center. The manufactured part can be traced back to the US Drug Enforcement Agency.
This week: A daring baboon breakout, Congress could ban Americans from eating their pets, and a cancerous mass that’s anything but.
Catch up on the latest pet and veterinary news from the last week. In this update: Reporting animal abuse becomes mandatory in parts of Canada, a cloned dog gets cloned, and yes, dogs are smarter than cats.
The opioid shortage isn’t going away any time soon. The shortage, which is severely affecting veterinarians’ ability to provide pain management for patients, is expected to last into 2019. The primary short-term cause is a production issue at a Pfizer, Inc. plant in Kansas, but residual hurricane damage in Puerto Rico, a major pharmaceutical manufacturing center, and a pre-existing Drug Enforcement Agency mandate to reduce the manufacture of opioid medication in the United States by 20% in 2018, are also having an effect.
This week: checking for microchips becomes law in New York, why more dogs aren't sniffing out cancer, and nipping compassion fatigue in the bud